This is a case report of CDC group Ve-1 bacteremia in an otherwise healthy patient with granulomatous hepatitis.
questionable clinical significance. Recently, two cases of infection with this organism were reported in patients with debilitating underlying disease (1, 7) . This is a report of CDC group Ve-1 bacteremia in a previously healthy patient with granulomatous hepatitis.
Case history. A 61-year-old male was admitted with a 6-week history of fatigue, low-grade temperature, generalized myalgia, and a 22-lb (ca. 10.kg) weight loss. About 1 month before admission, the patient was treated empirically with a 2-week course of oral erythromycin followed by a 2-week course of doxycycline with no clinical response. Laboratory evaluation at that time revealed a hemoglobin of 11.9 g/dl; a leukocyte count of 15,800/mm3 with 13% band forms, 84% polymorphonuclear forms, and 7% lymphocytes; serum iron of 17 mg/dl; and an alkaline phosphatase level of 246 Bodansky units. The patient had no significant medical history. He had no allergies and was not taking any medications.
The physical examination at his admission was normal except for a temperature of 102.5°F (ca. 39.2°C) taken orally. The initial chest roentgenogram and urinalysis were normal. Urine culture and blood cultures were sterile. Complete blood count revealed a hemoglobin of 10.7 g/dl and a leukocyte count of 13,000/mm3 with 5% band forms, 53% polymorphonuclear forms, 23% lymphocytes, and 13% monocytes. His rapid plasma reagin, rheumatoid factor, and antinuclear antibody tests were negative. Resolution of fever, myalgia, anorexia, and lethargy occurred after 4 days of antibiotic therapy. The leukocyte count and differential returned to normal, and the patient was discharged after 14 days of intravenous gentamicin and clindamycin. After 3 months, the patient had gained 5 lb (ca. 2.2 kg), was afebrile, and had a very mild elevation of alkaline phosphatase to 143 Bodansky units. After 6 months, the patient was asymptomatic and afebrile, had gained 10 lb (ca. 4.5 kg), and had a normal complete blood count and liver function tests.
Discussion. CDC group Ve-1, previously classified as Chromobacterium typhiflavum, is a gram-negative bacillus for which the name Pseudomonas luteola has been proposed (5). Only 14 clinical isolates had been reported before 1970 (8) , ana clinical illness with the organism has been recognized only recently. The two reported clinical infections caused by group Ve-1 were prosthetic valve endocarditis with onset 2 weeks after valve replacement (7) and bacteremia 'and acute hemorrhagic pancreatitis in a patient receiving steroids for systemic lupus erythematosus (1) .
The patient discussed in this report was previously healthy. He was found to have granulomatous hepatitis during his hospitalization. He did not have an intravenous catheter and had not had an invasive procedure at the time of the illness. This organism had never been isolated at our institutiQn from any source. The rapid clinical response of the patient to appropriate antibiotics, as evidenced by a normalization of temperature and leukocyte count as well as a feeling of well-being, suggests that the blood isolate was a pathogen and not a contaminant. The antibiotic susceptibilities of the organism were similar to those previously reported: it was susceptible to ampicillin, ticarcillin, mezlocillin, gentamicin, tobramycin, and amikacin and resistant to cefoxitin and trimethoprim-sulfamethoxazole (1, 8) . Resistance to ampicillin has been reported, although this strain was susceptible (3) .
The source of the CDC group Ve-1 bacteremia and its relationship to granulomatous hepatitis are unclear. Infections with Yersinia and Brucella spp. and mycobacteria have been associated with granulomatous hepatitis (6, 9) . There are no reports of nonfermentative gram-negative bacilli causing granulomatous hepatitis. The alkaline phosphatase level of the patient remained elevated for several months after antibiotic therapy and normalized 6 months later. It is possible that the granulomatous hepatitis was unrelated to the bacteremia (2) . The source of the bacteremia is unknown. This case of CDC group Ve-1 bacteremia in a healthy patient with granulomatous hepatitis broadens the spectrum of disease caused by this organism.
